DEFINITIVE HEALTHCARE CORP (DH) Fundamental Analysis & Valuation

NASDAQ:DH • US24477E1038

Current stock price

0.9862 USD
+0.03 (+3.47%)
At close:
0.9862 USD
0 (0%)
After Hours:

This DH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. DH Profitability Analysis

1.1 Basic Checks

  • In the past year DH was profitable.
  • In the past year DH had a positive cash flow from operations.
  • In the past 5 years DH always reported negative net income.
  • Each year in the past 5 years DH had a positive operating cash flow.
DH Yearly Net Income VS EBIT VS OCF VS FCFDH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M -300M -400M

1.2 Ratios

  • The Return On Assets of DH (-18.89%) is comparable to the rest of the industry.
  • The Return On Equity of DH (-49.42%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -18.89%
ROE -49.42%
ROIC N/A
ROA(3y)-22.63%
ROA(5y)-13.82%
ROE(3y)-55.3%
ROE(5y)-33.74%
ROIC(3y)N/A
ROIC(5y)N/A
DH Yearly ROA, ROE, ROICDH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80

1.3 Margins

  • With an excellent Gross Margin value of 75.88%, DH belongs to the best of the industry, outperforming 82.35% of the companies in the same industry.
  • In the last couple of years the Gross Margin of DH has remained more or less at the same level.
  • DH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 75.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.08%
GM growth 5Y0.44%
DH Yearly Profit, Operating, Gross MarginsDH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. DH Health Analysis

2.1 Basic Checks

  • DH does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for DH has been reduced compared to 1 year ago.
  • DH has less shares outstanding than it did 5 years ago.
  • DH has a worse debt/assets ratio than last year.
DH Yearly Shares OutstandingDH Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
DH Yearly Total Debt VS Total AssetsDH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • Based on the Altman-Z score of -0.93, we must say that DH is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of DH (-0.93) is worse than 61.76% of its industry peers.
  • DH has a debt to FCF ratio of 4.45. This is a neutral value as DH would need 4.45 years to pay back of all of its debts.
  • The Debt to FCF ratio of DH (4.45) is better than 67.65% of its industry peers.
  • A Debt/Equity ratio of 0.56 indicates that DH is somewhat dependend on debt financing.
  • The Debt to Equity ratio of DH (0.56) is worse than 73.53% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 4.45
Altman-Z -0.93
ROIC/WACCN/A
WACC8.15%
DH Yearly LT Debt VS Equity VS FCFDH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.3 Liquidity

  • DH has a Current Ratio of 1.64. This is a normal value and indicates that DH is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.64, DH is in line with its industry, outperforming 44.12% of the companies in the same industry.
  • DH has a Quick Ratio of 1.64. This is a normal value and indicates that DH is financially healthy and should not expect problems in meeting its short term obligations.
  • DH's Quick ratio of 1.64 is in line compared to the rest of the industry. DH outperforms 44.12% of its industry peers.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 1.64
DH Yearly Current Assets VS Current LiabilitesDH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. DH Growth Analysis

3.1 Past

  • DH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -28.57%.
  • The Earnings Per Share has been growing slightly by 1.37% on average over the past years.
  • Looking at the last year, DH shows a decrease in Revenue. The Revenue has decreased by -4.24% in the last year.
  • Measured over the past years, DH shows a quite strong growth in Revenue. The Revenue has been growing by 15.34% on average per year.
EPS 1Y (TTM)-28.57%
EPS 3Y1.37%
EPS 5YN/A
EPS Q2Q%-25%
Revenue 1Y (TTM)-4.24%
Revenue growth 3Y2.74%
Revenue growth 5Y15.34%
Sales Q2Q%-1.21%

3.2 Future

  • Based on estimates for the next years, DH will show a decrease in Earnings Per Share. The EPS will decrease by -0.37% on average per year.
  • The Revenue is expected to grow by 0.24% on average over the next years.
EPS Next Y-31.15%
EPS Next 2Y-12.38%
EPS Next 3Y-0.37%
EPS Next 5YN/A
Revenue Next Year-6.56%
Revenue Next 2Y-2.98%
Revenue Next 3Y0.24%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DH Yearly Revenue VS EstimatesDH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M 250M
DH Yearly EPS VS EstimatesDH Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0.1 0.2 0.3

More info and screens

Find the best growth stocksShow best growing peers

7

4. DH Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 3.94 indicates a rather cheap valuation of DH.
  • Based on the Price/Earnings ratio, DH is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 26.64, DH is valued rather cheaply.
  • The Price/Forward Earnings ratio is 5.73, which indicates a rather cheap valuation of DH.
  • DH's Price/Forward Earnings ratio is rather cheap when compared to the industry. DH is cheaper than 100.00% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of DH to the average of the S&P500 Index (21.36), we can say DH is valued rather cheaply.
Industry RankSector Rank
PE 3.94
Fwd PE 5.73
DH Price Earnings VS Forward Price EarningsDH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DH indicates a rather cheap valuation: DH is cheaper than 100.00% of the companies listed in the same industry.
  • DH's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DH is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.78
EV/EBITDA 1.68
DH Per share dataDH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-12.38%
EPS Next 3Y-0.37%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DH Dividend Analysis

5.1 Amount

  • DH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DH Fundamentals: All Metrics, Ratios and Statistics

DEFINITIVE HEALTHCARE CORP

NASDAQ:DH (5/1/2026, 8:21:51 PM)

After market: 0.9862 0 (0%)

0.9862

+0.03 (+3.47%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Industry Strength1.24
Industry Growth47.83
Earnings (Last)02-26
Earnings (Next)05-07
Inst Owners27.23%
Inst Owner Change0.05%
Ins Owners10.9%
Ins Owner Change21.21%
Market Cap103.03M
Revenue(TTM)241.52M
Net Income(TTM)-138.93M
Analysts75
Price Target2.6 (163.64%)
Short Float %10.07%
Short Ratio7.75
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.6%
Min EPS beat(2)-4.36%
Max EPS beat(2)23.57%
EPS beat(4)3
Avg EPS beat(4)39.3%
Min EPS beat(4)-4.36%
Max EPS beat(4)101.59%
EPS beat(8)6
Avg EPS beat(8)23.08%
EPS beat(12)9
Avg EPS beat(12)24.15%
EPS beat(16)13
Avg EPS beat(16)27%
Revenue beat(2)1
Avg Revenue beat(2)-0.86%
Min Revenue beat(2)-2%
Max Revenue beat(2)0.29%
Revenue beat(4)2
Avg Revenue beat(4)0.04%
Min Revenue beat(4)-2%
Max Revenue beat(4)2.29%
Revenue beat(8)2
Avg Revenue beat(8)-0.9%
Revenue beat(12)2
Avg Revenue beat(12)-1.16%
Revenue beat(16)4
Avg Revenue beat(16)-0.98%
PT rev (1m)-34.72%
PT rev (3m)-34.72%
EPS NQ rev (1m)-8.46%
EPS NQ rev (3m)-44.93%
EPS NY rev (1m)-17.94%
EPS NY rev (3m)-35.28%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)-3.19%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)-4.48%
Valuation
Industry RankSector Rank
PE 3.94
Fwd PE 5.73
P/S 0.43
P/FCF 2.78
P/OCF 1.92
P/B 0.37
P/tB N/A
EV/EBITDA 1.68
EPS(TTM)0.25
EY25.35%
EPS(NY)0.17
Fwd EY17.45%
FCF(TTM)0.35
FCFY35.97%
OCF(TTM)0.51
OCFY52.2%
SpS2.31
BVpS2.69
TBVpS-1.57
PEG (NY)N/A
PEG (5Y)N/A
Graham Number3.8905 (294.49%)
Profitability
Industry RankSector Rank
ROA -18.89%
ROE -49.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 75.88%
FCFM 15.34%
ROA(3y)-22.63%
ROA(5y)-13.82%
ROE(3y)-55.3%
ROE(5y)-33.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.08%
GM growth 5Y0.44%
F-Score5
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 4.45
Debt/EBITDA 3.95
Cap/Depr 29.8%
Cap/Sales 6.92%
Interest Coverage N/A
Cash Conversion 136.16%
Profit Quality N/A
Current Ratio 1.64
Quick Ratio 1.64
Altman-Z -0.93
F-Score5
WACC8.15%
ROIC/WACCN/A
Cap/Depr(3y)19.81%
Cap/Depr(5y)17.06%
Cap/Sales(3y)4.33%
Cap/Sales(5y)4.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.57%
EPS 3Y1.37%
EPS 5YN/A
EPS Q2Q%-25%
EPS Next Y-31.15%
EPS Next 2Y-12.38%
EPS Next 3Y-0.37%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.24%
Revenue growth 3Y2.74%
Revenue growth 5Y15.34%
Sales Q2Q%-1.21%
Revenue Next Year-6.56%
Revenue Next 2Y-2.98%
Revenue Next 3Y0.24%
Revenue Next 5YN/A
EBIT growth 1Y-70.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1.6%
EBIT Next 3Y-11.92%
EBIT Next 5YN/A
FCF growth 1Y-19.18%
FCF growth 3Y10.79%
FCF growth 5Y11.17%
OCF growth 1Y-7.59%
OCF growth 3Y14.76%
OCF growth 5Y18.29%

DEFINITIVE HEALTHCARE CORP / DH Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DEFINITIVE HEALTHCARE CORP?

ChartMill assigns a fundamental rating of 4 / 10 to DH.


What is the valuation status of DEFINITIVE HEALTHCARE CORP (DH) stock?

ChartMill assigns a valuation rating of 7 / 10 to DEFINITIVE HEALTHCARE CORP (DH). This can be considered as Undervalued.


What is the profitability of DH stock?

DEFINITIVE HEALTHCARE CORP (DH) has a profitability rating of 3 / 10.


Can you provide the financial health for DH stock?

The financial health rating of DEFINITIVE HEALTHCARE CORP (DH) is 4 / 10.